• Cromore Road, Coleraine Campus

    BT52 1SA Coleraine

    United Kingdom

  • 1666 Citations
  • 23 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Paul A. McCarron holds a Chair in Pharmaceutics and is currently the Head of School of Pharmacy and Pharmaceutical Sciences at Ulster University.A registered pharmacist and member of the Pharmaceutical Society of Northern Ireland, with experience of industrial and academic pharmacy, he has a particular interest in the development of advanced drug delivery systems with a expertise in translating novel delivery strategies into the clinical and commercial settings.He is currently a company director in Swedish Pharma and founder of Jenarron Therapeutics Ltd.  Both companies are at an early stage and in the preliminary rounds of raising seed capital funding to develop innovative topical dosages forms. The former company is concentrating on the development of bioadhesive oral patches, whilst Jenarron Therapeutics is commercialising a wound hydrogel for use in management of chronic wounds and acute laceration.Research InterestsProf McCarron’s research interests concern the development and characterisation of nanoparticulate systems and topical formulations. Following substantial funding from the Research and Development Office in Northern Ireland, Prof McCarron developed and trialed an innovative putty-type material for delivering anaesthesia to acute laceration.Results published recently in the Annals of Emergency Medicine, the foremost journal for emergency medicine research, demonstrate efficacy based on a non-inferiority study when compared to infiltration of lidocaine solution.FundingDepartment of Education for Northern Ireland.

External positions

Registered Pharmacist

1 Jan 1990 → …

Keywords

  • RL Dermatology
  • RM Therapeutics. Pharmacology
  • RS Pharmacy and materia medica

Fingerprint Dive into the research topics where Paul Mc Carron is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Aminolevulinic Acid Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Photochemotherapy Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Drug Delivery Systems Medicine & Life Sciences
Photosensitizing Agents Medicine & Life Sciences
Skin Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Anti-invasive and anti-proliferative effects of shRNA-loaded poly(lactide-co-glycolide) nanoparticles following RAN silencing in MDA-MB231 breast cancer cells

Sharma, A., McCarron, P. A., Matchett, K., Hawthorne, S. & El Tanani, M., 1 Feb 2019, 36, 2, p. 26- 13 p., 26.

Research output: Contribution to journalArticle

Open Access
File
Polyglactin 910
Nanoparticles
Small Interfering RNA
Breast Neoplasms
Cell Movement

Design, Stability and Efficacy of a New Targeting Peptide for Nanoparticulate Drug Delivery to SH-SY5Y Neuroblastoma Cells

Huey, R., Rathbone, D., McCarron, P. A. & Hawthorne, S., 31 Jan 2019, 27, 9, p. 959-970 12 p.

Research output: Contribution to journalArticle

amsonic acid
Neuroblastoma
Peptides
Rabies virus
Nanoparticles

Does the PRP of those with diabetes have antimicrobial properties?

Cundell, J., Hughes, C. & McCarron, P. A., May 2019.

Research output: Contribution to conferencePoster

Diabetic Foot
Methicillin Resistance
Proteus vulgaris
Wounds and Injuries
Biofilms

Emergence of three dimensional printed cardiac tissue: Opportunities and challenges in cardiovascular diseases.

Charbe, N., Zacconi, F., Amnerkar, N., Pardhi, D., Shukla, P., Mukattash, T., McCarron, P. A. & Tambuwala, M. M., 12 Jan 2019, 15, 3, p. 188-204 17 p.

Research output: Contribution to journalReview article

Tissue Engineering
Cardiovascular Diseases
Biocompatible Materials
Cellular Microenvironment
Hydrogel

FRANKINCENSE ESSENTIAL OIL SUPPRESSES MELANOMA CANCER THROUGH DOWN REGULATION OF BCL-2/BAX CASCADE SIGNALING AND AMELORATE HEPTOTOXICITY VIA PHASE I AND II DRUG METABOLISING ENZYMES

Faruk, H., Bakshi, H., Khan, S., Nasef, M., Farzand, R., Rashan, L., MS, A-B., SS, H., McCarron, P. A. & Tambuwala, M. M., 28 May 2019, 10, 37, p. 3472 3490 p.

Research output: Contribution to journalArticle

Open Access
File
Volatile Oils
Melanoma
Down-Regulation
Enzymes
Pharmaceutical Preparations